Antenatal dexamethasone and decreased severity of retinopathy of prematurity

Archives of Ophthalmology

Volumn 116, Issue 5, 1998, Pages 601-605

  Higgins, Rosemary D ^a,b   Mendelsohn, Alan L ^a   DeFeo, Michael J ^a   Ucsel, Raif ^a   Hendricks Munoz, Karen D ^a  

^a BELLEVUE HOSPITAL CENTER   (United States)

^b GEORGETOWN UNIVERSITY MEDICAL CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

DEXAMETHASONE;

ARTICLE; BIRTH WEIGHT; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; CRYOSURGERY; DISEASE SEVERITY; FEMALE; GESTATIONAL AGE; HUMAN; INFANT; LASER SURGERY; LUNG DYSPLASIA; MAJOR CLINICAL STUDY; MALE; NEWBORN; PATENT DUCTUS ARTERIOSUS; PRENATAL PERIOD; PRIORITY JOURNAL; RESPIRATORY DISTRESS SYNDROME; RETROLENTAL FIBROPLASIA; RISK FACTOR;

EID: 0031710707     PISSN: 00039950     EISSN: None     Source Type: Journal    
DOI: 10.1001/archopht.116.5.601     Document Type: Article

References (18)

1. Hack M, Fanaroff AA. Outcome of extremely immature infants: a perinatal dilemma. N Engl J Med. 1993;329:1649-1650.
2. Ptielps DL. Retinopathy of prematurity. Pediatr Clin North Am. 1993;40:705-714.
3. Higgins RD. Retinopamy of prematurity. Resident Staff Physician. 1996;42:66-68.
4. Cryotherapy for Retinopathy of Prematurity Cooperative Group. Multicenter trial of cryotherapy for retinopathy of prematurity: preliminary results. Pediatrics. 1988;81:697-706.
5. McNamara JA, Tasmar W, Brown CG, et al. Laser photocoagulation for stage 3+ retinopathy of prematurity. Ophthalmology. 1991;98:576-580.
6. Hunter DG, Repka MX. Diode laser photocoagulation for threshold retinopathy of prematurity: a randomized study. Ophthalmology. 1993;100:238-244.
7. Clinical considerations for the use of oxygen. In: Guidelines for Perinatal Care. 3rd ed. Elk Grove Village, III: American Academy of Pediatrics: 1994:197-203.
8. An international classification of retinopathy of prematurity. Pediatrics. 1984;74:127-133.
9. Quinn GE, Dobson V, Repka MX, et al. Development of myopia in infants with birth weights less than 1251 grams. Ophthalmology. 1992;99:329-340.
10. Robinson R, O'Keefe M. Follow-up study on premature infants with and without retinopathy of prematurity. Br J Opbthalmol. 1993;77:91-94.
11. Dobson V, Quinn GE, Summers CG, et al. Effect of acute-phase retinopathy of prematurity on grating acuity development in the very low birth weight infant. Invest Ophthalmol Vis Sci. 1994;35:4236-4244.
12. Palmer EA, Rynn JT, Hardy RJ, et al. Incidence and early course of retinopathy of prematurity. Ophthalmology. 1991;98:1628-1640.
13. NIH Consensus Development Panel on the Effect of Corticosteroids for Fetal Maturation on Perinatal Outcomes. The effect of corticosteroid for fetal maturation on perinatal outcomes. JAMA. 1995;273:413-418.
14. Charles JB, Ganthier R. Appiah AP. Incidence and characteristics of retinopathy of prematurity in a low-income inner-city population. Ophthalmology. 1991;98:14-17.
15. Moise AA, Weardon ME, Kozineb CA, Gest AL, Welty SE, Hansen TN. Antenatal steroids are associated with less need for blood pressure support in extremely premature infants. Pediatrics. 1995;95:845-850.
16. Horbar J, for the investigators of the Vermont-Oxford Trials Network. Antenatal corticosteroid treatment and neonatal outcomes for infants 501-1500 grams in the Vermont-Oxford Trials Network. Am J Obstet Gynecol. 1995;173:275-281.
17. Danis RP, Bingaman DP, Yang Y, Ladd B. Inhibition of preretinal and optic nerve head neovascularization in pigs by intravitreal triamcinolone acetonide. Ophthalmology. 1996;103:2099-2104.
18. Ishibashi T, Miki K, Sorgenti N, Patterson R, Ryan SJ. Effects of steroids on experimental subretinal neovascularization in the subhuman primate. Arch Ophthalmol. 1985;03:708-711.